Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Colleoni

Showing results (111-120 of 264) with videos related to

Pageof 27
Sort By:
Clinical Breast Cancer|August 11, 2015
Outcome and Medial Presentation of Breast Cancer: European Institute of Oncology ExperienceEmilia Montagna, Vincenzo Bagnardi, Nicole Rotmensz, et al.
Breast (Edinburgh, Scotland)|May 6, 2008
Topoisomerase IIalpha gene status and prediction of pathological complete remission after anthracycline-based neoadjuvant chemotherapy in endocrine non-responsive Her2/neu-positive breast cancerLaura Orlando, Barbara Del Curto, Sara Gandini, et al.
Breast Cancer Research : BCR|June 22, 2014
Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypesPatrick Maisonneuve, Davide Disalvatore, Nicole Rotmensz, et al.
Breast Cancer Research and Treatment|February 9, 2008
Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93Beat Thürlimann, Karen N Price, Richard D Gelber, et al.
Clinical Breast Cancer|April 19, 2014
Outcome of male breast cancer: a matched single-institution seriesMonica Iorfida, Vincenzo Bagnardi, Nicole Rotmensz, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 16, 2018
Oncoplastic breast surgery for the management of ductal carcinoma in situ (DCIS): is it oncologically safe? A retrospective cohort analysisFrancesca De Lorenzi, Julien Di Bella, Patrick Maisonneuve, et al.
Breast Cancer Research and Treatment|March 9, 2012
Invasive lobular breast cancer: subtypes and outcomeMonica Iorfida, Eugenio Maiorano, Enrico Orvieto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvementMarco Colleoni, Nicole Rotmensz, Giulia Peruzzotti, et al.
Clinical Breast Cancer|December 12, 2013
Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expressionAlessandra Balduzzi, Vincenzo Bagnardi, Nicole Rotmensz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2008
Research issues affecting preoperative systemic therapy for operable breast cancerAntonio C Wolff, Donald Berry, Lisa A Carey, et al.
Pageof 27

Showing results (111-120 of 264) with videos related to

Sort By:
Pageof 27
Clinical Breast Cancer|August 11, 2015
Outcome and Medial Presentation of Breast Cancer: European Institute of Oncology ExperienceEmilia Montagna, Vincenzo Bagnardi, Nicole Rotmensz, et al.
Breast (Edinburgh, Scotland)|May 6, 2008
Topoisomerase IIalpha gene status and prediction of pathological complete remission after anthracycline-based neoadjuvant chemotherapy in endocrine non-responsive Her2/neu-positive breast cancerLaura Orlando, Barbara Del Curto, Sara Gandini, et al.
Breast Cancer Research : BCR|June 22, 2014
Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypesPatrick Maisonneuve, Davide Disalvatore, Nicole Rotmensz, et al.
Breast Cancer Research and Treatment|February 9, 2008
Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93Beat Thürlimann, Karen N Price, Richard D Gelber, et al.
Clinical Breast Cancer|April 19, 2014
Outcome of male breast cancer: a matched single-institution seriesMonica Iorfida, Vincenzo Bagnardi, Nicole Rotmensz, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 16, 2018
Oncoplastic breast surgery for the management of ductal carcinoma in situ (DCIS): is it oncologically safe? A retrospective cohort analysisFrancesca De Lorenzi, Julien Di Bella, Patrick Maisonneuve, et al.
Breast Cancer Research and Treatment|March 9, 2012
Invasive lobular breast cancer: subtypes and outcomeMonica Iorfida, Eugenio Maiorano, Enrico Orvieto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvementMarco Colleoni, Nicole Rotmensz, Giulia Peruzzotti, et al.
Clinical Breast Cancer|December 12, 2013
Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expressionAlessandra Balduzzi, Vincenzo Bagnardi, Nicole Rotmensz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2008
Research issues affecting preoperative systemic therapy for operable breast cancerAntonio C Wolff, Donald Berry, Lisa A Carey, et al.
Pageof 27